Publications (11) LAURA OJEDA MÁRQUEZ publications

2023

  1. Inhibition of HSP90 in Driver Oncogene-Defined Lung Adenocarcinoma Cell Lines: Key Proteins Underpinning Therapeutic Efficacy

    International Journal of Molecular Sciences, Vol. 24, Núm. 18

2021

  1. Identification of predictive biomarkers of response to hsp90 inhibitors in lung adenocarcinoma

    International Journal of Molecular Sciences, Vol. 22, Núm. 5, pp. 1-18

2020

  1. Blood Predictive Biomarkers for Patients With Non–small-cell Lung Cancer Associated With Clinical Response to Nivolumab

    Clinical Lung Cancer, Vol. 21, Núm. 1, pp. 75-85

  2. FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacy

    EBioMedicine, Vol. 53

2019

  1. FGFR1 Cooperates with EGFR in Lung Cancer Oncogenesis, and Their Combined Inhibition Shows Improved Efficacy

    Journal of Thoracic Oncology, Vol. 14, Núm. 4, pp. 641-655

  2. FGFR4 increases EGFR oncogenic signaling in lung adenocarcinoma, and their combined inhibition is highly effective

    Lung Cancer, Vol. 131, pp. 112-121

  3. Impact of Heat Shock Protein 90 Inhibition on the Proteomic Profile of Lung Adenocarcinoma as Measured by Two-Dimensional Electrophoresis Coupled with Mass Spectrometry

    Cells, Vol. 8, Núm. 8

2018

  1. Corrigendum to "Proteomic-Based Approaches for the Study of Cytokines in Lung Cancer"

    Disease markers

  2. The FGFR4-388arg Variant Promotes Lung Cancer Progression by N-Cadherin Induction

    Scientific Reports, Vol. 8, Núm. 1

2016

  1. 20P Context-dependent role of FGFR4 in lung tumorogenesis

    Journal of Thoracic Oncology, Vol. 11, Núm. 4, pp. S64

  2. Proteomic-based approaches for the study of cytokines in lung cancer

    Disease Markers, Vol. 2016